SAN FRANCISCO — Dr. Thomas Insel is one of the most high-profile scientists who has departed Verily Life Sciences, the Google spinoff that has been plagued by turnover at the top and questions about its approach to science.

Insel, a neuroscientist and longtime head of the National Institute of Mental Health, left for a venture that he says could use people’s behavior on smartphones — such as the speed and cadence of their typing and scrolling — to improve diagnosis and treatment of mental health. The idea, he said in an interview, is to apply the kind of precision approach used for cancer or heart disease to “predict and preempt” serious mental illness.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • I’m editor of STAT Plus, STAT’s subscriber-only service for pharma, biotech, business, and policy coverage. STAT is a sister publication to the Globe, which means that we are separate. Globe editors will sometimes present STAT and STAT Plus stories that they think Globe readers would find interesting, in much the same way that some newsletters will aggregate links to a variety of other media outlets with distinct subscription services to add context and value for their readership.

    At this time STAT and the Globe do not have a bundled subscription service, and as such our subscription entities are distinct. That said, we do offer a 25 percent discount to Globe subscribers if they are interested in STAT Plus. You can use the code GLOBE17 at checkout (www.statnews.com/subscribe) to redeem this offer. Or, you can learn more about STAT Plus here: https://www.statnews.com/stat-plus/faq/

    Liz Cooney
    STAT

  • So – Mark responded that he agreed.
    Is Mark from STAT or The Boston Globe?
    And – now what?
    Thanks,
    Laurie

  • Why do I need to subscribe to STAT –
    as it is listed as a Boston Globe article?
    It seems to me that if the Boston Globe puts the article in their paper,
    they should provide the article…..
    Please respond.
    Thank you,
    Laurie Abrams-Hall
    laurieabramshall@gmail.com

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy